Annual CAPEX
$28.01 M
+$7.91 M+39.37%
31 December 2023
Summary:
Ionis Pharmaceuticals annual capital expenditures is currently $28.01 million, with the most recent change of +$7.91 million (+39.37%) on 31 December 2023. During the last 3 years, it has fallen by -$13.04 million (-31.76%). IONS annual CAPEX is now -31.76% below its all-time high of $41.05 million, reached on 31 December 2020.IONS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
-$3.69 M
-$23.95 M-118.23%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly capital expenditures is currently -$3.69 million, with the most recent change of -$23.95 million (-118.23%) on 30 September 2024. Over the past year, it has dropped by -$6.93 million (-213.98%). IONS quarterly CAPEX is now -118.23% below its all-time high of $20.26 million, reached on 30 June 2024.IONS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$22.27 M
-$6.93 M-23.75%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM capital expenditures is currently $22.27 million, with the most recent change of -$6.93 million (-23.75%) on 30 September 2024. Over the past year, it has dropped by -$10.77 million (-32.61%). IONS TTM CAPEX is now -53.54% below its all-time high of $47.93 million, reached on 30 June 2020.IONS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.4% | -214.0% | -32.6% |
| 3 y3 years | -31.8% | -180.3% | +7.1% |
| 5 y5 years | +58.7% | -120.8% | -24.4% |
IONS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -31.8% | +56.5% | -118.2% | at low | -39.6% | +34.0% |
| 5 y | 5 years | -31.8% | +58.7% | -118.2% | at low | -53.5% | +34.0% |
| alltime | all time | -31.8% | +3012.3% | -118.2% | at low | -53.5% | >+9999.0% |
Ionis Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.69 M(-118.2%) | $22.27 M(-23.7%) |
| June 2024 | - | $20.26 M(+253.6%) | $29.20 M(+32.7%) |
| Mar 2024 | - | $5.73 M(<-9900.0%) | $22.02 M(-21.4%) |
| Dec 2023 | $28.01 M(+39.4%) | -$27.00 K(-100.8%) | $28.01 M(-15.2%) |
| Sept 2023 | - | $3.24 M(-75.2%) | $33.04 M(-10.4%) |
| June 2023 | - | $13.07 M(+11.5%) | $36.86 M(+30.3%) |
| Mar 2023 | - | $11.72 M(+134.2%) | $28.29 M(+40.8%) |
| Dec 2022 | $20.10 M(+12.3%) | $5.01 M(-29.1%) | $20.10 M(+5.3%) |
| Sept 2022 | - | $7.06 M(+56.8%) | $19.08 M(+14.8%) |
| June 2022 | - | $4.50 M(+27.5%) | $16.62 M(-9.8%) |
| Mar 2022 | - | $3.53 M(-11.5%) | $18.43 M(+3.0%) |
| Dec 2021 | $17.90 M(-56.4%) | $3.99 M(-13.3%) | $17.90 M(-13.9%) |
| Sept 2021 | - | $4.60 M(-27.1%) | $20.79 M(-28.7%) |
| June 2021 | - | $6.31 M(+110.4%) | $29.16 M(-14.4%) |
| Mar 2021 | - | $3.00 M(-56.4%) | $34.06 M(-17.0%) |
| Dec 2020 | $41.05 M(+13.1%) | $6.87 M(-47.0%) | $41.05 M(-4.8%) |
| Sept 2020 | - | $12.97 M(+15.7%) | $43.12 M(-10.0%) |
| June 2020 | - | $11.22 M(+12.3%) | $47.93 M(+14.1%) |
| Mar 2020 | - | $9.98 M(+11.6%) | $42.01 M(+15.8%) |
| Dec 2019 | $36.28 M(+105.5%) | $8.94 M(-49.7%) | $36.28 M(+23.2%) |
| Sept 2019 | - | $17.79 M(+236.1%) | $29.45 M(+79.9%) |
| June 2019 | - | $5.29 M(+24.2%) | $16.37 M(-13.1%) |
| Mar 2019 | - | $4.26 M(+101.6%) | $18.83 M(+6.7%) |
| Dec 2018 | $17.65 M(-53.4%) | $2.11 M(-55.1%) | $17.65 M(-21.9%) |
| Sept 2018 | - | $4.71 M(-39.3%) | $22.60 M(-40.0%) |
| June 2018 | - | $7.75 M(+151.5%) | $37.64 M(+2.5%) |
| Mar 2018 | - | $3.08 M(-56.4%) | $36.72 M(-3.0%) |
| Dec 2017 | $37.86 M(+228.4%) | $7.07 M(-64.2%) | $37.86 M(+9.3%) |
| Sept 2017 | - | $19.75 M(+189.3%) | $34.63 M(+102.3%) |
| June 2017 | - | $6.83 M(+61.8%) | $17.12 M(+16.1%) |
| Mar 2017 | - | $4.22 M(+9.9%) | $14.74 M(+27.8%) |
| Dec 2016 | $11.53 M(-1.9%) | $3.84 M(+72.3%) | $11.53 M(+6.5%) |
| Sept 2016 | - | $2.23 M(-49.9%) | $10.82 M(-6.1%) |
| June 2016 | - | $4.45 M(+340.4%) | $11.52 M(+3.2%) |
| Mar 2016 | - | $1.01 M(-67.8%) | $11.16 M(-5.0%) |
| Dec 2015 | $11.75 M(+5.8%) | $3.13 M(+7.1%) | $11.75 M(-11.7%) |
| Sept 2015 | - | $2.93 M(-28.5%) | $13.31 M(+11.8%) |
| June 2015 | - | $4.09 M(+156.2%) | $11.90 M(+8.5%) |
| Mar 2015 | - | $1.60 M(-66.0%) | $10.96 M(-1.3%) |
| Dec 2014 | $11.10 M(+107.1%) | $4.69 M(+208.5%) | $11.10 M(+39.8%) |
| Sept 2014 | - | $1.52 M(-51.8%) | $7.94 M(-6.5%) |
| June 2014 | - | $3.15 M(+81.7%) | $8.49 M(+37.5%) |
| Mar 2014 | - | $1.74 M(+13.6%) | $6.17 M(+15.1%) |
| Dec 2013 | $5.36 M(+3.7%) | $1.53 M(-26.3%) | $5.36 M(+3.3%) |
| Sept 2013 | - | $2.07 M(+147.3%) | $5.19 M(+16.0%) |
| June 2013 | - | $838.00 K(-9.3%) | $4.48 M(-20.5%) |
| Mar 2013 | - | $924.00 K(-32.0%) | $5.63 M(+8.9%) |
| Dec 2012 | $5.17 M(-62.7%) | $1.36 M(+0.1%) | $5.17 M(-16.7%) |
| Sept 2012 | - | $1.36 M(-32.0%) | $6.20 M(-27.8%) |
| June 2012 | - | $1.99 M(+331.6%) | $8.59 M(-23.6%) |
| Mar 2012 | - | $462.00 K(-80.7%) | $11.24 M(-18.9%) |
| Dec 2011 | $13.87 M(-21.0%) | $2.39 M(-36.1%) | $13.87 M(+7.8%) |
| Sept 2011 | - | $3.74 M(-19.5%) | $12.86 M(+17.5%) |
| June 2011 | - | $4.65 M(+50.6%) | $10.94 M(+20.0%) |
| Mar 2011 | - | $3.09 M(+122.7%) | $9.12 M(-48.1%) |
| Dec 2010 | $17.56 M(+7.7%) | $1.39 M(-23.9%) | $17.56 M(-7.0%) |
| Sept 2010 | - | $1.82 M(-35.5%) | $18.89 M(-0.3%) |
| June 2010 | - | $2.82 M(-75.5%) | $18.95 M(-22.6%) |
| Mar 2010 | - | $11.53 M(+324.2%) | $24.47 M(+50.2%) |
| Dec 2009 | $16.29 M(-4.5%) | $2.72 M(+44.4%) | $16.29 M(-22.4%) |
| Sept 2009 | - | $1.88 M(-77.5%) | $21.01 M(-9.8%) |
| June 2009 | - | $8.35 M(+149.0%) | $23.30 M(+22.9%) |
| Mar 2009 | - | $3.35 M(-54.9%) | $18.96 M(+11.1%) |
| Dec 2008 | $17.07 M(+240.7%) | $7.43 M(+78.1%) | $17.07 M(+58.2%) |
| Sept 2008 | - | $4.17 M(+4.2%) | $10.79 M(+30.1%) |
| June 2008 | - | $4.00 M(+174.9%) | $8.29 M(+48.7%) |
| Mar 2008 | - | $1.46 M(+26.6%) | $5.57 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $5.01 M(+96.0%) | $1.15 M(-31.3%) | $5.01 M(-5.7%) |
| Sept 2007 | - | $1.68 M(+29.9%) | $5.31 M(+23.5%) |
| June 2007 | - | $1.29 M(+44.5%) | $4.30 M(+52.6%) |
| Mar 2007 | - | $893.00 K(-38.5%) | $2.82 M(+10.3%) |
| Dec 2006 | $2.56 M(-11.0%) | $1.45 M(+118.5%) | $2.56 M(-28.6%) |
| Sept 2006 | - | $665.00 K(-444.6%) | $3.58 M(+27.2%) |
| June 2006 | - | -$193.00 K(-130.6%) | $2.81 M(-12.8%) |
| Mar 2006 | - | $631.00 K(-74.5%) | $3.23 M(+12.3%) |
| Dec 2005 | $2.87 M(-18.5%) | $2.48 M(-2551.5%) | $2.87 M(+90.3%) |
| Sept 2005 | - | -$101.00 K(-145.7%) | $1.51 M(-36.7%) |
| June 2005 | - | $221.00 K(-20.2%) | $2.39 M(-35.5%) |
| Mar 2005 | - | $277.00 K(-75.1%) | $3.70 M(+4.9%) |
| Dec 2004 | $3.53 M(-53.3%) | $1.11 M(+43.4%) | $3.53 M(-7.9%) |
| Sept 2004 | - | $776.00 K(-49.4%) | $3.83 M(-0.5%) |
| June 2004 | - | $1.53 M(+1389.3%) | $3.85 M(-6.2%) |
| Mar 2004 | - | $103.00 K(-92.7%) | $4.10 M(-45.7%) |
| Dec 2003 | $7.55 M(-79.5%) | $1.42 M(+78.1%) | $7.55 M(-62.2%) |
| Sept 2003 | - | $795.00 K(-55.6%) | $19.99 M(-32.7%) |
| June 2003 | - | $1.79 M(-49.7%) | $29.73 M(-13.0%) |
| Mar 2003 | - | $3.55 M(-74.4%) | $34.16 M(-7.3%) |
| Dec 2002 | $36.83 M(+296.6%) | $13.86 M(+31.6%) | $36.83 M(+35.8%) |
| Sept 2002 | - | $10.53 M(+69.3%) | $27.11 M(+44.8%) |
| June 2002 | - | $6.22 M(-0.2%) | $18.73 M(+29.9%) |
| Mar 2002 | - | $6.23 M(+50.6%) | $14.42 M(+55.3%) |
| Dec 2001 | $9.29 M(+463.2%) | $4.14 M(+92.8%) | $9.29 M(+130.7%) |
| Sept 2001 | - | $2.15 M(+12.2%) | $4.03 M(+7.9%) |
| June 2001 | - | $1.91 M(+74.8%) | $3.73 M(+74.2%) |
| Mar 2001 | - | $1.09 M(-197.2%) | $2.14 M(+29.9%) |
| Dec 2000 | $1.65 M(-65.6%) | -$1.13 M(-160.8%) | $1.65 M(-60.5%) |
| Sept 2000 | - | $1.85 M(+473.1%) | $4.17 M(-13.5%) |
| June 2000 | - | $323.00 K(-46.3%) | $4.82 M(+34.0%) |
| Mar 2000 | - | $601.00 K(-57.1%) | $3.60 M(-25.0%) |
| Dec 1999 | $4.80 M(+9.1%) | $1.40 M(-44.0%) | $4.80 M(-4.0%) |
| Sept 1999 | - | $2.50 M(-377.8%) | $5.00 M(+47.1%) |
| June 1999 | - | -$900.00 K(-150.0%) | $3.40 M(-33.3%) |
| Mar 1999 | - | $1.80 M(+12.5%) | $5.10 M(+15.9%) |
| Dec 1998 | $4.40 M(+25.7%) | $1.60 M(+77.8%) | $4.40 M(+69.2%) |
| Sept 1998 | - | $900.00 K(+12.5%) | $2.60 M(+73.3%) |
| June 1998 | - | $800.00 K(-27.3%) | $1.50 M(-21.1%) |
| Mar 1998 | - | $1.10 M(-650.0%) | $1.90 M(-45.7%) |
| Dec 1997 | $3.50 M(+288.9%) | -$200.00 K(0.0%) | $3.50 M(-5.4%) |
| Sept 1997 | - | -$200.00 K(-116.7%) | $3.70 M(-7.5%) |
| June 1997 | - | $1.20 M(-55.6%) | $4.00 M(+25.0%) |
| Mar 1997 | - | $2.70 M(>+9900.0%) | $3.20 M(+255.6%) |
| Dec 1996 | $900.00 K(-18.2%) | $0.00(-100.0%) | $900.00 K(-43.8%) |
| Sept 1996 | - | $100.00 K(-75.0%) | $1.60 M(-11.1%) |
| June 1996 | - | $400.00 K(0.0%) | $1.80 M(+28.6%) |
| Mar 1996 | - | $400.00 K(-42.9%) | $1.40 M(+27.3%) |
| Dec 1995 | $1.10 M(+22.2%) | $700.00 K(+133.3%) | $1.10 M(+22.2%) |
| Sept 1995 | - | $300.00 K(>+9900.0%) | $900.00 K(+125.0%) |
| June 1995 | - | $0.00(-100.0%) | $400.00 K(-20.0%) |
| Mar 1995 | - | $100.00 K(-80.0%) | $500.00 K(-44.4%) |
| Dec 1994 | $900.00 K(-82.7%) | $500.00 K(-350.0%) | $900.00 K(-71.9%) |
| Sept 1994 | - | -$200.00 K(-300.0%) | $3.20 M(-28.9%) |
| June 1994 | - | $100.00 K(-80.0%) | $4.50 M(-11.8%) |
| Mar 1994 | - | $500.00 K(-82.1%) | $5.10 M(-1.9%) |
| Dec 1993 | $5.20 M(+147.6%) | $2.80 M(+154.5%) | $5.20 M(+205.9%) |
| Sept 1993 | - | $1.10 M(+57.1%) | $1.70 M(-32.0%) |
| June 1993 | - | $700.00 K(+16.7%) | $2.50 M(+4.2%) |
| Mar 1993 | - | $600.00 K(-185.7%) | $2.40 M(+14.3%) |
| Dec 1992 | $2.10 M(-27.6%) | -$700.00 K(-136.8%) | $2.10 M(-41.7%) |
| Sept 1992 | - | $1.90 M(+216.7%) | $3.60 M(+100.0%) |
| June 1992 | - | $600.00 K(+100.0%) | $1.80 M(-40.0%) |
| Mar 1992 | - | $300.00 K(-62.5%) | $3.00 M(+3.4%) |
| Dec 1991 | $2.90 M | $800.00 K(+700.0%) | $2.90 M(+38.1%) |
| Sept 1991 | - | $100.00 K(-94.4%) | $2.10 M(+5.0%) |
| June 1991 | - | $1.80 M(+800.0%) | $2.00 M(+900.0%) |
| Mar 1991 | - | $200.00 K | $200.00 K |
FAQ
- What is Ionis Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual CAPEX year-on-year change?
- What is Ionis Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Ionis Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM CAPEX year-on-year change?
What is Ionis Pharmaceuticals annual capital expenditures?
The current annual CAPEX of IONS is $28.01 M
What is the all time high annual CAPEX for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual capital expenditures is $41.05 M
What is Ionis Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, IONS annual capital expenditures has changed by +$7.91 M (+39.37%)
What is Ionis Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of IONS is -$3.69 M
What is the all time high quarterly CAPEX for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly capital expenditures is $20.26 M
What is Ionis Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, IONS quarterly capital expenditures has changed by -$6.93 M (-213.98%)
What is Ionis Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of IONS is $22.27 M
What is the all time high TTM CAPEX for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM capital expenditures is $47.93 M
What is Ionis Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, IONS TTM capital expenditures has changed by -$10.77 M (-32.61%)